GlassScriptPhysician profile
Elfat Rumman
NPI 1811266208
$3,157.27
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,029 · 2020: $782 · 2021: $848 · 2022: $208 · 2023: $185 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.74 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,092.78 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $489.02 | 2019-2021 | |
| Lilly USA, LLC | $233.85 | 2019-2024 | Mounjaro |
| Pfizer INC. | $187.37 | 2019-2024 | |
| Glaxosmithkline, LLC. | $138.91 | 2019-2023 | Shingrix, Trelegy Ellipta |
| Eisai INC. | $137.39 | 2020-2021 | |
| Abbvie INC. | $124.99 | 2021 | |
| Amgen INC. | $112.79 | 2019-2021 | |
| Lucid Diagnostics INC. | $84.27 | 2021 | |
| Boston Scientific Corporation | $83.07 | 2021-2023 | |
| Radius Health, INC. | $67.85 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.68 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $39.74 | 2019 | |
| Allergan, INC. | $34.91 | 2020 | |
| Abiomed | $32.46 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $27.28 | 2022 | |
| Arbor Pharmaceuticals, INC. | $25.35 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| Merck Sharp & Dohme LLC | $23.01 | 2020 | |
| Abbott Laboratories | $20.94 | 2023 | Proclaim |
| Biogen, INC. | $20.69 | 2020 | |
| Esperion Therapeutics, INC. | $19.96 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.39 | 2021 | |
| Corcept Therapeutics | $17.55 | 2020 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Dexcom, INC. | $13.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.82 | 2019 | |
| Medtronic Minimed, INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elfat Rumman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.